Life expectancy for women with metastatic breast cancer (MBC) has increased as advances have been made in treatment and management. Consequently, when measuring the burden of MBC, womens' experiences, quality of life, and gaps in information and support needs should be considered. The BRIDGE Surve...
Overall survival outcomes in older patients with metastatic breast cancer: A National Cancer Database analysis.doi:10.1200/JCO.2023.41.16_suppl.120497433212049#Background:Over the last few decades, improvements in healthcare have increased life expectancy by nearly 10 years resulting in a rise ...
Anatomy diagram obtained from Cancer Research UK/Wikimedia Commons, available under a Creative Commons Attribution-Share Alike 4.0 International license: https://commons.wikimedia.org/wiki/File:Diagram_showing_advanced_bladder_cancer_CRUK_441.svg. b Abundance of ctDNA in relation to patient ...
The life expectancy of patients has been increasing considerably over the recent years since the development of cancer management, but the occurrence chance of bone metastasis also increased. The incidence rate ranges from 20% to 85%, varying by type of cancers. Bone metastasis is the major ...
Not intended for US, Canadian and UK-based media Firstapprovedimmunotherapyfor rare and aggressive skin cancer in the European Union, with initial launchesplannedinGermanyandtheUK Buildson Bavencio's previous accelerated approvals in the US and recent approvalinSwitzerland ...
Design, Setting, and Participants Multicenter noninferiority randomized clinical trial conducted in 42 UK and 5 Australian radiotherapy centers. Eligible patients (n = 686) had metastatic cancer with spinal cord or cauda equina compression, life expectancy greater than 8 weeks, and no previous ra...
Be Resilient to Breast Cancer, on survival in metastatic breast cancer: a randomised, controlled intervention trial Zeng Jie Ye*,1,6, Hong Zhong Qiu*,2,6, Mu Zi Liang1,6, Mei Ling Liu3,6, Peng Fei Li1, Peng Chen1, Zhe Sun4, Yuan Liang Yu2, Shu Ni Wang2, Zhang Zhang3, Kun ...
Regression analysis of grouped survival data with application to breast cancer data Biometrics (1978), pp. 57-67 CrossrefView in ScopusGoogle Scholar [13] H.I. Hurwitz, et al. Phase II randomized trial of sequential or concurrent FOLFOXIRI‐bevacizumab versus FOLFOX‐bevacizumab for metastatic colo...
UK; 2CancerCare Manitoba, St Boniface General Hospital, 409 Tache` Avenue, Winnipeg, Manitoba, Canada R2H 2A6; 3Academic Medical Center, Meibergdreef 9, Amsterdam 1105 AZ, The Netherlands; 4Imelda GI Clinical Research Center, Imeldalaan 9, Bonheiden B-2820, Belgium; 5Institut de Cancerologie...
Brain metastases (BM) is a common complication, especially with advanced-stage melanoma. Melanoma accounts for almost 10 percent of BM and the third leading cause after lung and breast cancer.[11]In a large multi-institutional adjuvant study, the incidence of BM is about 15 percent in...